Global Drug Testing Software
Global Drug Testing Software

Drug Testing Software Comprehensive Study by Enterprise Size (Large Enterprises, Small & Medium Enterprises), Deployment Type (On-premises, Cloud-based), Platform (Windows, IOS, Android, Others), Industry Vertical (Financial Services, Healthcare, Retail, Staffing, Manufacturing, Transportation & Construction, Energy & Utilities, Others), Pricing (One-time License, Monthly Subscription, Others) Players and Region - Global Market Outlook to 2025

Drug Testing Software Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 208 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Drug testing software helps to identify and manage drug and alcohol testing programs that help organizations to streamline the drug testing process for new hires and provide ongoing testing for employees. Also, it provides companies, employees, and candidates with solutions to manage or run drug testing businesses. The feature of the software includes drug testing data management, result tracking, Department of Transportation (DOT) compliance, and more. These solutions offered in conjunction with background check software and often integrates with applicant tracking systems (ATS).

The market study is being classified and major geographies with country level break-up.

US Drug Test Centers (United States), VICTIG Screening Solutions (United States), Cority (Canada), IntelliCorp (United States), Sterling Talent Solutions (United States), Checkr (United States), Verified First (United States), AssureHire (United States), Core Screening (United States) and TestVault (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are TATSoftApps (United States), National Drug Screening (Australia), PeopleG2 (United States), Drug Test Network (United States), applya Occupational Strategies (United States) and GoodHire (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Drug Testing Software market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Drug Testing Software market by Type, Application and Region.

On the basis of geography, the market of Drug Testing Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Demand From Small and Medium Businesses, And End-Use Industry Owing To Increased Efficiency, Expanded Access, and Complete Visibility
  • Increasing Rate of Employment in Various Sectors
  • Real-Time Status Updates of All Testing Available
  • Time and Money Saving With an Efficient Electronic Process for Ordering Tests and Receiving Test Results

Market Trend
  • Implementing Artificial Intelligence (AI) in Drug Testing Software
  • Integrations with Other Software such as Quest, LabCorp

Restraints
  • Lack of Awareness among Business Firms and Industry
  • Low Budget of Small Enterprises

Opportunities
  • Stringent Government Regulations for Employers, and Other Industries

Challenges
  • Compliance with the Laws and Regulations such as DOT and Non-DoT
  • Lack of Expertise in the Workforce


On May 07, 2019, Intellicorp Records, Inc., a Verisk business, has announced an advanced drug screening solution integrated into the companyís background check ordering process. Employers can now help manage their drug screening and background check program from a single platform.
In the United States, the government has mandated that the employment offered in many fields (corporate, state, transportation, and the like) must include drug and alcohol tests. Most places will also periodically drug and alcohol test their personnel, just to make sure that they arenít using and that work is being done in a safe manner. This brings to the two main types of drug testing, DOT and non-DOT drug and alcohol testing.

Key Target Audience
Drug Testing Software Developers, Software Engineers and Developers, Regulatory Bodies, Government & NGO, Commercial Research & Development (R&D) Institutions, Research Organizations, and Consulting Firms, End-use industries and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Enterprise Size
  • Large Enterprises
  • Small & Medium Enterprises

By Deployment Type
  • On-premises
  • Cloud-based

By Platform
  • Windows
  • IOS
  • Android
  • Others

By Industry Vertical
  • Financial Services
  • Healthcare
  • Retail
  • Staffing
  • Manufacturing
  • Transportation & Construction
  • Energy & Utilities
  • Others

By Pricing
  • One-time License
  • Monthly Subscription
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand From Small and Medium Businesses, And End-Use Industry Owing To Increased Efficiency, Expanded Access, and Complete Visibility
      • 3.2.2. Increasing Rate of Employment in Various Sectors
      • 3.2.3. Real-Time Status Updates of All Testing Available
      • 3.2.4. Time and Money Saving With an Efficient Electronic Process for Ordering Tests and Receiving Test Results
    • 3.3. Market Challenges
      • 3.3.1. Compliance with the Laws and Regulations such as DOT and Non-DoT
      • 3.3.2. Lack of Expertise in the Workforce
    • 3.4. Market Trends
      • 3.4.1. Implementing Artificial Intelligence (AI) in Drug Testing Software
      • 3.4.2. Integrations with Other Software such as Quest, LabCorp
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Testing Software, by Enterprise Size, Deployment Type, Platform, Industry Vertical, Pricing and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Drug Testing Software (Value)
      • 5.2.1. Global Drug Testing Software by: Enterprise Size (Value)
        • 5.2.1.1. Large Enterprises
        • 5.2.1.2. Small & Medium Enterprises
      • 5.2.2. Global Drug Testing Software by: Deployment Type (Value)
        • 5.2.2.1. On-premises
        • 5.2.2.2. Cloud-based
      • 5.2.3. Global Drug Testing Software by: Platform (Value)
        • 5.2.3.1. Windows
        • 5.2.3.2. IOS
        • 5.2.3.3. Android
        • 5.2.3.4. Others
      • 5.2.4. Global Drug Testing Software by: Industry Vertical (Value)
        • 5.2.4.1. Financial Services
        • 5.2.4.2. Healthcare
        • 5.2.4.3. Retail
        • 5.2.4.4. Staffing
        • 5.2.4.5. Manufacturing
        • 5.2.4.6. Transportation & Construction
        • 5.2.4.7. Energy & Utilities
        • 5.2.4.8. Others
      • 5.2.5. Global Drug Testing Software by: Pricing (Value)
        • 5.2.5.1. One-time License
        • 5.2.5.2. Monthly Subscription
        • 5.2.5.3. Others
      • 5.2.6. Global Drug Testing Software Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Drug Testing Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. US Drug Test Centers (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. VICTIG Screening Solutions (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cority (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IntelliCorp (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sterling Talent Solutions (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Checkr (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Verified First (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AssureHire (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Core Screening (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TestVault (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Drug Testing Software Sale, by Enterprise Size, Deployment Type, Platform, Industry Vertical, Pricing and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Drug Testing Software (Value)
      • 7.2.1. Global Drug Testing Software by: Enterprise Size (Value)
        • 7.2.1.1. Large Enterprises
        • 7.2.1.2. Small & Medium Enterprises
      • 7.2.2. Global Drug Testing Software by: Deployment Type (Value)
        • 7.2.2.1. On-premises
        • 7.2.2.2. Cloud-based
      • 7.2.3. Global Drug Testing Software by: Platform (Value)
        • 7.2.3.1. Windows
        • 7.2.3.2. IOS
        • 7.2.3.3. Android
        • 7.2.3.4. Others
      • 7.2.4. Global Drug Testing Software by: Industry Vertical (Value)
        • 7.2.4.1. Financial Services
        • 7.2.4.2. Healthcare
        • 7.2.4.3. Retail
        • 7.2.4.4. Staffing
        • 7.2.4.5. Manufacturing
        • 7.2.4.6. Transportation & Construction
        • 7.2.4.7. Energy & Utilities
        • 7.2.4.8. Others
      • 7.2.5. Global Drug Testing Software by: Pricing (Value)
        • 7.2.5.1. One-time License
        • 7.2.5.2. Monthly Subscription
        • 7.2.5.3. Others
      • 7.2.6. Global Drug Testing Software Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Testing Software: by Enterprise Size(USD Million)
  • Table 2. Drug Testing Software Large Enterprises , by Region USD Million (2014-2019)
  • Table 3. Drug Testing Software Small & Medium Enterprises , by Region USD Million (2014-2019)
  • Table 4. Drug Testing Software: by Deployment Type(USD Million)
  • Table 5. Drug Testing Software On-premises , by Region USD Million (2014-2019)
  • Table 6. Drug Testing Software Cloud-based , by Region USD Million (2014-2019)
  • Table 7. Drug Testing Software: by Platform(USD Million)
  • Table 8. Drug Testing Software Windows , by Region USD Million (2014-2019)
  • Table 9. Drug Testing Software IOS , by Region USD Million (2014-2019)
  • Table 10. Drug Testing Software Android , by Region USD Million (2014-2019)
  • Table 11. Drug Testing Software Others , by Region USD Million (2014-2019)
  • Table 12. Drug Testing Software: by Industry Vertical(USD Million)
  • Table 13. Drug Testing Software Financial Services , by Region USD Million (2014-2019)
  • Table 14. Drug Testing Software Healthcare , by Region USD Million (2014-2019)
  • Table 15. Drug Testing Software Retail , by Region USD Million (2014-2019)
  • Table 16. Drug Testing Software Staffing , by Region USD Million (2014-2019)
  • Table 17. Drug Testing Software Manufacturing , by Region USD Million (2014-2019)
  • Table 18. Drug Testing Software Transportation & Construction , by Region USD Million (2014-2019)
  • Table 19. Drug Testing Software Energy & Utilities , by Region USD Million (2014-2019)
  • Table 20. Drug Testing Software Others , by Region USD Million (2014-2019)
  • Table 21. Drug Testing Software: by Pricing(USD Million)
  • Table 22. Drug Testing Software One-time License , by Region USD Million (2014-2019)
  • Table 23. Drug Testing Software Monthly Subscription , by Region USD Million (2014-2019)
  • Table 24. Drug Testing Software Others , by Region USD Million (2014-2019)
  • Table 25. South America Drug Testing Software, by Country USD Million (2014-2019)
  • Table 26. South America Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 27. South America Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 28. South America Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 29. South America Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 30. South America Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 31. Brazil Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 32. Brazil Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 33. Brazil Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 34. Brazil Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 35. Brazil Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 36. Argentina Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 37. Argentina Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 38. Argentina Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 39. Argentina Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 40. Argentina Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 41. Rest of South America Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 42. Rest of South America Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 43. Rest of South America Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 44. Rest of South America Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 45. Rest of South America Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 46. Asia Pacific Drug Testing Software, by Country USD Million (2014-2019)
  • Table 47. Asia Pacific Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 48. Asia Pacific Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 49. Asia Pacific Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 50. Asia Pacific Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 51. Asia Pacific Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 52. China Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 53. China Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 54. China Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 55. China Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 56. China Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 57. Japan Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 58. Japan Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 59. Japan Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 60. Japan Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 61. Japan Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 62. India Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 63. India Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 64. India Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 65. India Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 66. India Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 67. South Korea Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 68. South Korea Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 69. South Korea Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 70. South Korea Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 71. South Korea Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 72. Taiwan Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 73. Taiwan Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 74. Taiwan Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 75. Taiwan Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 76. Taiwan Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 77. Australia Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 78. Australia Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 79. Australia Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 80. Australia Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 81. Australia Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 84. Rest of Asia-Pacific Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 85. Rest of Asia-Pacific Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 86. Rest of Asia-Pacific Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 87. Europe Drug Testing Software, by Country USD Million (2014-2019)
  • Table 88. Europe Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 89. Europe Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 90. Europe Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 91. Europe Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 92. Europe Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 93. Germany Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 94. Germany Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 95. Germany Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 96. Germany Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 97. Germany Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 98. France Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 99. France Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 100. France Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 101. France Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 102. France Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 103. Italy Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 104. Italy Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 105. Italy Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 106. Italy Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 107. Italy Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 108. United Kingdom Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 109. United Kingdom Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 110. United Kingdom Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 111. United Kingdom Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 112. United Kingdom Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 113. Netherlands Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 114. Netherlands Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 115. Netherlands Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 116. Netherlands Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 117. Netherlands Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 118. Rest of Europe Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 119. Rest of Europe Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 120. Rest of Europe Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 121. Rest of Europe Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 122. Rest of Europe Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 123. MEA Drug Testing Software, by Country USD Million (2014-2019)
  • Table 124. MEA Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 125. MEA Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 126. MEA Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 127. MEA Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 128. MEA Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 129. Middle East Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 130. Middle East Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 131. Middle East Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 132. Middle East Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 133. Middle East Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 134. Africa Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 135. Africa Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 136. Africa Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 137. Africa Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 138. Africa Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 139. North America Drug Testing Software, by Country USD Million (2014-2019)
  • Table 140. North America Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 141. North America Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 142. North America Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 143. North America Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 144. North America Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 145. United States Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 146. United States Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 147. United States Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 148. United States Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 149. United States Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 150. Canada Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 151. Canada Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 152. Canada Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 153. Canada Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 154. Canada Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 155. Mexico Drug Testing Software, by Enterprise Size USD Million (2014-2019)
  • Table 156. Mexico Drug Testing Software, by Deployment Type USD Million (2014-2019)
  • Table 157. Mexico Drug Testing Software, by Platform USD Million (2014-2019)
  • Table 158. Mexico Drug Testing Software, by Industry Vertical USD Million (2014-2019)
  • Table 159. Mexico Drug Testing Software, by Pricing USD Million (2014-2019)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Drug Testing Software: by Enterprise Size(USD Million)
  • Table 171. Drug Testing Software Large Enterprises , by Region USD Million (2020-2025)
  • Table 172. Drug Testing Software Small & Medium Enterprises , by Region USD Million (2020-2025)
  • Table 173. Drug Testing Software: by Deployment Type(USD Million)
  • Table 174. Drug Testing Software On-premises , by Region USD Million (2020-2025)
  • Table 175. Drug Testing Software Cloud-based , by Region USD Million (2020-2025)
  • Table 176. Drug Testing Software: by Platform(USD Million)
  • Table 177. Drug Testing Software Windows , by Region USD Million (2020-2025)
  • Table 178. Drug Testing Software IOS , by Region USD Million (2020-2025)
  • Table 179. Drug Testing Software Android , by Region USD Million (2020-2025)
  • Table 180. Drug Testing Software Others , by Region USD Million (2020-2025)
  • Table 181. Drug Testing Software: by Industry Vertical(USD Million)
  • Table 182. Drug Testing Software Financial Services , by Region USD Million (2020-2025)
  • Table 183. Drug Testing Software Healthcare , by Region USD Million (2020-2025)
  • Table 184. Drug Testing Software Retail , by Region USD Million (2020-2025)
  • Table 185. Drug Testing Software Staffing , by Region USD Million (2020-2025)
  • Table 186. Drug Testing Software Manufacturing , by Region USD Million (2020-2025)
  • Table 187. Drug Testing Software Transportation & Construction , by Region USD Million (2020-2025)
  • Table 188. Drug Testing Software Energy & Utilities , by Region USD Million (2020-2025)
  • Table 189. Drug Testing Software Others , by Region USD Million (2020-2025)
  • Table 190. Drug Testing Software: by Pricing(USD Million)
  • Table 191. Drug Testing Software One-time License , by Region USD Million (2020-2025)
  • Table 192. Drug Testing Software Monthly Subscription , by Region USD Million (2020-2025)
  • Table 193. Drug Testing Software Others , by Region USD Million (2020-2025)
  • Table 194. South America Drug Testing Software, by Country USD Million (2020-2025)
  • Table 195. South America Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 196. South America Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 197. South America Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 198. South America Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 199. South America Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 200. Brazil Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 201. Brazil Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 202. Brazil Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 203. Brazil Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 204. Brazil Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 205. Argentina Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 206. Argentina Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 207. Argentina Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 208. Argentina Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 209. Argentina Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 210. Rest of South America Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 211. Rest of South America Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 212. Rest of South America Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 213. Rest of South America Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 214. Rest of South America Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 215. Asia Pacific Drug Testing Software, by Country USD Million (2020-2025)
  • Table 216. Asia Pacific Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 217. Asia Pacific Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 218. Asia Pacific Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 219. Asia Pacific Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 220. Asia Pacific Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 221. China Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 222. China Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 223. China Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 224. China Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 225. China Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 226. Japan Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 227. Japan Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 228. Japan Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 229. Japan Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 230. Japan Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 231. India Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 232. India Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 233. India Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 234. India Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 235. India Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 236. South Korea Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 237. South Korea Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 238. South Korea Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 239. South Korea Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 240. South Korea Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 241. Taiwan Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 242. Taiwan Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 243. Taiwan Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 244. Taiwan Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 245. Taiwan Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 246. Australia Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 247. Australia Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 248. Australia Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 249. Australia Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 250. Australia Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 251. Rest of Asia-Pacific Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 252. Rest of Asia-Pacific Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 253. Rest of Asia-Pacific Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 254. Rest of Asia-Pacific Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 255. Rest of Asia-Pacific Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 256. Europe Drug Testing Software, by Country USD Million (2020-2025)
  • Table 257. Europe Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 258. Europe Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 259. Europe Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 260. Europe Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 261. Europe Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 262. Germany Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 263. Germany Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 264. Germany Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 265. Germany Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 266. Germany Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 267. France Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 268. France Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 269. France Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 270. France Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 271. France Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 272. Italy Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 273. Italy Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 274. Italy Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 275. Italy Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 276. Italy Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 277. United Kingdom Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 278. United Kingdom Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 279. United Kingdom Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 280. United Kingdom Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 281. United Kingdom Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 282. Netherlands Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 283. Netherlands Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 284. Netherlands Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 285. Netherlands Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 286. Netherlands Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 287. Rest of Europe Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 288. Rest of Europe Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 289. Rest of Europe Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 290. Rest of Europe Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 291. Rest of Europe Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 292. MEA Drug Testing Software, by Country USD Million (2020-2025)
  • Table 293. MEA Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 294. MEA Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 295. MEA Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 296. MEA Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 297. MEA Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 298. Middle East Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 299. Middle East Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 300. Middle East Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 301. Middle East Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 302. Middle East Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 303. Africa Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 304. Africa Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 305. Africa Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 306. Africa Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 307. Africa Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 308. North America Drug Testing Software, by Country USD Million (2020-2025)
  • Table 309. North America Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 310. North America Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 311. North America Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 312. North America Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 313. North America Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 314. United States Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 315. United States Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 316. United States Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 317. United States Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 318. United States Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 319. Canada Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 320. Canada Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 321. Canada Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 322. Canada Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 323. Canada Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 324. Mexico Drug Testing Software, by Enterprise Size USD Million (2020-2025)
  • Table 325. Mexico Drug Testing Software, by Deployment Type USD Million (2020-2025)
  • Table 326. Mexico Drug Testing Software, by Platform USD Million (2020-2025)
  • Table 327. Mexico Drug Testing Software, by Industry Vertical USD Million (2020-2025)
  • Table 328. Mexico Drug Testing Software, by Pricing USD Million (2020-2025)
  • Table 329. Research Programs/Design for This Report
  • Table 330. Key Data Information from Secondary Sources
  • Table 331. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Testing Software: by Enterprise Size USD Million (2014-2019)
  • Figure 5. Global Drug Testing Software: by Deployment Type USD Million (2014-2019)
  • Figure 6. Global Drug Testing Software: by Platform USD Million (2014-2019)
  • Figure 7. Global Drug Testing Software: by Industry Vertical USD Million (2014-2019)
  • Figure 8. Global Drug Testing Software: by Pricing USD Million (2014-2019)
  • Figure 9. South America Drug Testing Software Share (%), by Country
  • Figure 10. Asia Pacific Drug Testing Software Share (%), by Country
  • Figure 11. Europe Drug Testing Software Share (%), by Country
  • Figure 12. MEA Drug Testing Software Share (%), by Country
  • Figure 13. North America Drug Testing Software Share (%), by Country
  • Figure 14. Global Drug Testing Software share by Players 2019 (%)
  • Figure 15. Global Drug Testing Software share by Players (Top 3) 2019(%)
  • Figure 16. Global Drug Testing Software share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. US Drug Test Centers (United States) Revenue, Net Income and Gross profit
  • Figure 19. US Drug Test Centers (United States) Revenue: by Geography 2019
  • Figure 20. VICTIG Screening Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 21. VICTIG Screening Solutions (United States) Revenue: by Geography 2019
  • Figure 22. Cority (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Cority (Canada) Revenue: by Geography 2019
  • Figure 24. IntelliCorp (United States) Revenue, Net Income and Gross profit
  • Figure 25. IntelliCorp (United States) Revenue: by Geography 2019
  • Figure 26. Sterling Talent Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 27. Sterling Talent Solutions (United States) Revenue: by Geography 2019
  • Figure 28. Checkr (United States) Revenue, Net Income and Gross profit
  • Figure 29. Checkr (United States) Revenue: by Geography 2019
  • Figure 30. Verified First (United States) Revenue, Net Income and Gross profit
  • Figure 31. Verified First (United States) Revenue: by Geography 2019
  • Figure 32. AssureHire (United States) Revenue, Net Income and Gross profit
  • Figure 33. AssureHire (United States) Revenue: by Geography 2019
  • Figure 34. Core Screening (United States) Revenue, Net Income and Gross profit
  • Figure 35. Core Screening (United States) Revenue: by Geography 2019
  • Figure 36. TestVault (United States) Revenue, Net Income and Gross profit
  • Figure 37. TestVault (United States) Revenue: by Geography 2019
  • Figure 38. Global Drug Testing Software: by Enterprise Size USD Million (2020-2025)
  • Figure 39. Global Drug Testing Software: by Deployment Type USD Million (2020-2025)
  • Figure 40. Global Drug Testing Software: by Platform USD Million (2020-2025)
  • Figure 41. Global Drug Testing Software: by Industry Vertical USD Million (2020-2025)
  • Figure 42. Global Drug Testing Software: by Pricing USD Million (2020-2025)
  • Figure 43. South America Drug Testing Software Share (%), by Country
  • Figure 44. Asia Pacific Drug Testing Software Share (%), by Country
  • Figure 45. Europe Drug Testing Software Share (%), by Country
  • Figure 46. MEA Drug Testing Software Share (%), by Country
  • Figure 47. North America Drug Testing Software Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • US Drug Test Centers (United States)
  • VICTIG Screening Solutions (United States)
  • Cority (Canada)
  • IntelliCorp (United States)
  • Sterling Talent Solutions (United States)
  • Checkr (United States)
  • Verified First (United States)
  • AssureHire (United States)
  • Core Screening (United States)
  • TestVault (United States)
Additional players considered in the study are as follows:
TATSoftApps (United States) , National Drug Screening (Australia) , PeopleG2 (United States) , Drug Test Network (United States) , applya Occupational Strategies (United States) , GoodHire (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation